...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

BREAKING:  Hollister Biosciences Provides Update on Q2 2020, Generated Record Quarterly Revenue of CDN$ 11.5 Million

  • CDN$ 1.375 million in EBITDA
  • Bureau of Cannabis Control officially renewed its cannabis distribution license for the next year through August 2021
  • "We are very pleased with our revenue growth year to date.  Sales of cannabis related products have proven to be resilient throughout the COVID-19 pandemic.  We hope to continue to deliver strong results as the year progresses" stated Carl Saling, CEO.

Hollister large

Hub On AGORACOM / Read Release

Message: So....for warrants

Thanks for the link, golfyeti, which I was familiar with. But the point is that BT status is not a form of approval, it’s a recognition that a drug is looking promising for an important condition on the basis of preliminary data, and merits expedited development with the FDA’s support. See:

https://www.fda.gov/regulatory-information/food-and-drug-administration-safety-and-innovation-act-fdasia/frequently-asked-questions-breakthrough-therapies

Share
New Message
Please login to post a reply